Search Results

There are 2610 results for: content related to: 2012 ACR/ARHP Annual Scientific Meeting Late-Breaking Abstracts

  1. You have free access to this content
    Oral apremilast in the treatment of active psoriatic arthritis: Results of a multicenter, randomized, double-blind, placebo-controlled study

    Arthritis & Rheumatism

    Volume 64, Issue 10, October 2012, Pages: 3156–3167, Georg Schett, Jurgen Wollenhaupt, Kim Papp, Rik Joos, Jude F. Rodrigues, Adele R. Vessey, ChiaChi Hu, Randall Stevens and Kurt L. de Vlam

    Article first published online : 27 SEP 2012, DOI: 10.1002/art.34627

  2. You have free access to this content
    ACR Meeting

    Arthritis & Rheumatism

    Volume 64, Issue S10, October 2012, Pages: S1–S1216,

    Article first published online : 11 OCT 2012, DOI: 10.1002/art.37735

  3. You have full text access to this OnlineOpen article
    The impact of co-administration of ketoconazole and rifampicin on the pharmacokinetics of apremilast in healthy volunteers

    British Journal of Clinical Pharmacology

    Volume 78, Issue 5, November 2014, Pages: 1050–1057, Yong Liu, Simon Zhou, Yuntao Wan, Anfan Wu and Maria Palmisano

    Article first published online : 20 OCT 2014, DOI: 10.1111/bcp.12448

  4. Efficacy and safety of apremilast in subjects with moderate to severe plaque psoriasis: results from a phase II, multicenter, randomized, double-blind, placebo-controlled, parallel-group, dose-comparison study

    Journal of the European Academy of Dermatology and Venereology

    Volume 27, Issue 3, March 2013, Pages: e376–e383, K.A. Papp, R. Kaufmann, D. Thaçi, C. Hu, D. Sutherland and P. Rohane

    Article first published online : 3 OCT 2012, DOI: 10.1111/j.1468-3083.2012.04716.x

  5. You have full text access to this OnlineOpen article
    Apremilast, a cAMP phosphodiesterase-4 inhibitor, demonstrates anti-inflammatory activity in vitro and in a model of psoriasis

    British Journal of Pharmacology

    Volume 159, Issue 4, February 2010, Pages: 842–855, PH Schafer, A Parton, AK Gandhi, L Capone, M Adams, L Wu, JB Bartlett, MA Loveland, A Gilhar, Y-F Cheung, GS Baillie, MD Houslay, H-W Man, GW Muller and DI Stirling

    Article first published online : 24 DEC 2009, DOI: 10.1111/j.1476-5381.2009.00559.x

  6. You have full text access to this OnlineOpen article
    The pharmacokinetic effect of coadministration of apremilast and methotrexate in individuals with rheumatoid arthritis and psoriatic arthritis

    Clinical Pharmacology in Drug Development

    Volume 3, Issue 6, November/December 2014, Pages: 456–465, Yong Liu, Simon Zhou, James Nissel, Anfan Wu, Henry Lau and Maria Palmisano

    Article first published online : 8 MAY 2014, DOI: 10.1002/cpdd.109

  7. You have free access to this content
    Apremilast for the treatment of psoriasis and psoriatic arthritis

    Future Prescriber

    Volume 14, Issue 1, July 2013, Pages: 8–9, Steve Chaplin

    Article first published online : 1 AUG 2013, DOI: 10.1002/fps.102

  8. 2012 American College of Clinical Pharmacology Annual Meeting September 23rd–25th San Diego, California

    Clinical Pharmacology in Drug Development

    Volume 1, Issue 4, October 2012, Page: 175,

    Article first published online : 10 JAN 2013, DOI: 10.1177/2160763X12454673

    Corrected by:

    Errata: ERRATUM

    Vol. 2, Issue 1, 99, Article first published online: 11 MAR 2013

  9. Apremilast in the Treatment of Chronic Prostatitis/Chronic Pelvic Pain Syndrome: A Pilot Study

    LUTS: Lower Urinary Tract Symptoms

    Volume 4, Issue 3, September 2012, Pages: 140–143, Gregory P. McLENNAN, Iyad KHOURDAJI, Kim A. KILLINGER, Judith A. BOURA and Kenneth M. PETERS

    Article first published online : 29 MAR 2012, DOI: 10.1111/j.1757-5672.2012.00150.x

  10. Abstracts Thirty-Ninth Annual Meeting American College of Clinical Pharmacology September 12–14, 2010 Baltimore, Maryland

    The Journal of Clinical Pharmacology

    Volume 50, Issue 9, September 2010, Pages: 1058–1095,

    Article first published online : 7 MAR 2013, DOI: 10.1177/0091270009379561

  11. Abstracts 40th Annual Meeting of the American College of Clinical Pharmacology September 11–13, 2011 Chicago, Illinois

    The Journal of Clinical Pharmacology

    Volume 51, Issue 9, September 2011, Pages: 1326–1369,

    Article first published online : 7 MAR 2013, DOI: 10.1177/0091270010418046

  12. You have free access to this content
    ARA Scientific Posters

    Internal Medicine Journal

    Volume 44, Issue S2, May 2014, Pages: 10–37,

    Article first published online : 16 APR 2014, DOI: 10.1111/imj.12426

  13. Poster Session III (PIII 1–85)

    Clinical Pharmacology & Therapeutics

    Volume 89, Issue S1, February 2011, Pages: S68–S94,

    Article first published online : 22 FEB 2011, DOI: 10.1038/clpt.2010.335

  14. You have free access to this content
    47th Annual Scientific Meeting

    Australasian Journal of Dermatology

    Volume 55, Issue S1, May 2014, Pages: 1–58,

    Article first published online : 15 MAY 2014, DOI: 10.1111/ajd.12174

  15. Apremilast

    Standard Article

    Handbook of Metabolic Pathways of Xenobiotics

    Xin Zhou

    Published Online : 1 OCT 2014, DOI: 10.1002/9781118541203.xen342

  16. You have full text access to this OnlineOpen article
    Head-to-head comparison of subcutaneous abatacept versus adalimumab for rheumatoid arthritis: Findings of a phase IIIb, multinational, prospective, randomized study

    Arthritis & Rheumatism

    Volume 65, Issue 1, January 2013, Pages: 28–38, Michael E. Weinblatt, Michael Schiff, Robert Valente, Désirée van der Heijde, Gustavo Citera, Cathy Zhao, Michael Maldonado and Roy Fleischmann

    Article first published online : 27 DEC 2012, DOI: 10.1002/art.37711

  17. You have free access to this content
    ‘Bamboo spine’, a thing of the past?

    International Journal of Rheumatic Diseases

    Volume 17, Issue 2, February 2014, Pages: 127–130, Nigil Haroon and Debashish Danda

    Article first published online : 27 FEB 2014, DOI: 10.1111/1756-185X.12326

  18. You have free access to this content
    Phase IIb dose-ranging study of the oral JAK inhibitor tofacitinib (CP-690,550) or adalimumab monotherapy versus placebo in patients with active rheumatoid arthritis with an inadequate response to disease-modifying antirheumatic drugs

    Arthritis & Rheumatism

    Volume 64, Issue 3, March 2012, Pages: 617–629, Roy Fleischmann, Maurizio Cutolo, Mark C. Genovese, Eun Bong Lee, Keith S. Kanik, Seth Sadis, Carol A. Connell, David Gruben, Sriram Krishnaswami, Gene Wallenstein, Bethanie E. Wilkinson and Samuel H. Zwillich

    Article first published online : 28 FEB 2012, DOI: 10.1002/art.33383

  19. You have free access to this content
    Kinase inhibitors: The next generation of therapies in the treatment of rheumatoid arthritis

    International Journal of Rheumatic Diseases

    Volume 17, Issue 4, May 2014, Pages: 359–368, Lindsey A. MacFarlane and Derrick J. Todd

    Article first published online : 27 JAN 2014, DOI: 10.1111/1756-185X.12293

  20. You have free access to this content
    Roflumilast inhibits the release of chemokines and TNF-α from human lung macrophages stimulated with lipopolysaccharide

    British Journal of Pharmacology

    Volume 165, Issue 6, March 2012, Pages: 1877–1890, A Buenestado, S Grassin-Delyle, F Guitard, E Naline, C Faisy, D Israël-Biet, E Sage, JF Bellamy, H Tenor and P Devillier

    Article first published online : 22 FEB 2012, DOI: 10.1111/j.1476-5381.2011.01667.x